ORAPI EUR1ORAPI EUR1ORAPI EUR1

ORAPI EUR1

No trades
See on Supercharts
Market capitalization
‪43.15 M‬EUR
−2.88EUR
‪−18.82 M‬EUR
‪229.10 M‬EUR
‪2.20 M‬
Beta (1Y)
0.59

About ORAPI

CEO
Guy Chifflot
Headquarters
Saint-Vulbas
Website
Employees (FY)
916
Founded
1976
ISIN
FR0000075392
FIGI
BBG00JHVW648
Orapi SA engages in the design, manufacture, and distribution of hygiene products and industrial processes. It operates through the following geographical segments: Northern Europe, Southern Europe, North America, and Asia and Rest of the world. Its products are known under the brand names Garcin Bactynil, Orapi Hygiene, Spado, Fury, Gloss, and Wyritol. The company was founded by Guy Chifflot on August 14, 1968 and is headquartered in Saint-Vulbas, France.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of 0ICI is 6.56 EUR — it has increased by 2.18% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on LSE exchange ORAPI EUR1 stocks are traded under the ticker 0ICI.
0ICI stock is 2.13% volatile and has beta coefficient of 0.59. Check out the list of the most volatile stocks — is ORAPI EUR1 there?
Yes, you can track ORAPI EUR1 financials in yearly and quarterly reports right on TradingView.
0ICI net income for the last quarter is ‪−13.00 M‬ EUR, while the quarter before that showed ‪−5.82 M‬ EUR of net income which accounts for −123.39% change. Track more ORAPI EUR1 financial stats to get the full picture.
No, 0ICI doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, 0ICI shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ORAPI EUR1 stock right from TradingView charts — choose your broker and connect to your account.
0ICI reached its all-time high on Jan 16, 2018 with the price of 11.70 EUR, and its all-time low was 6.24 EUR and was reached on Jul 23, 2021.
See other stocks reaching their highest and lowest prices.
As of Apr 26, 2024, the company has 916.00 employees. See our rating of the largest employees — is ORAPI EUR1 on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ORAPI EUR1 technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ORAPI EUR1 stock shows the buy signal. See more of ORAPI EUR1 technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on ORAPI EUR1 future price: according to them, 0ICI price has a max estimate of 6.00 EUR and a min estimate of 6.00 EUR. Read a more detailed ORAPI EUR1 forecast: see what analysts think of ORAPI EUR1 and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. ORAPI EUR1 EBITDA is ‪12.75 M‬ EUR, and current EBITDA margin is 5.50%. See more stats in ORAPI EUR1 financial statements.